| Hepatitis C virus genetic variability and evolution N Echeverría, G Moratorio, J Cristina, P Moreno World journal of hepatology 7 (6), 831, 2015 | 156 | 2015 |
| Human endogenous retrovirus np9 gene is over expressed in chronic lymphocytic leukemia patients S Fischer, N Echeverría, G Moratorio, AI Landoni, G Dighiero, J Cristina, ... Leukemia research reports 3 (2), 70-72, 2014 | 36 | 2014 |
| Large expert-curated database for benchmarking document similarity detection in biomedical literature search P Brown, AC Tan, MA El-Esawi, T Liehr, O Blanck, DP Gladue, ... Database 2019, 2019 | 34 | 2019 |
| miRNA independent hepacivirus variants suggest a strong evolutionary pressure to maintain miR-122 dependence Y Yu, TKH Scheel, JM Luna, H Chung, E Nishiuchi, MA Scull, ... PLoS pathogens 13 (10), e1006694, 2017 | 33 | 2017 |
| Emergence of KPC-producing Klebsiella pneumoniae in Uruguay: infection control and molecular characterization C Marquez, A Ingold, N Echeverría, A Acevedo, R Vignoli, ... New microbes and new infections 2 (3), 58-63, 2014 | 32 | 2014 |
| IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients N Echeverría, D Chiodi, P López, AS Ciceron, J Angulo, M López-Lastra, ... Virology journal 15 (1), 1-10, 2018 | 29 | 2018 |
| Evaluation of SYBR Green real time PCR for detecting SARS-CoV-2 from clinical samples M Pereira-Gómez, Á Fajardo, N Echeverría, F López-Tort, ... Journal of virological methods 289, 114035, 2021 | 26 | 2021 |
| Association of Single-Nucleotide Polymorphisms in IL28B, but Not TNF-α, With Severity of Disease Caused by Andes Virus J Angulo, K Pino, N Echeverría-Chagas, C Marco, ... Clinical Infectious Diseases 61 (12), e62-e69, 2015 | 20 | 2015 |
| Naturally occurring NS3 resistance-associated variants in hepatitis C virus genotype 1: their relevance for developing countries N Echeverría, G Betancour, F Gámbaro, N Hernández, P López, D Chiodi, ... Virus Research 223, 140-146, 2016 | 16 | 2016 |
| Pretreatment hepatitis C virus NS5A/NS5B resistance-associated substitutions in genotype 1 Uruguayan infected patients F Aldunate, N Echeverría, D Chiodi, P López, A Sánchez-Cicerón, ... Disease Markers 2018, 2018 | 14 | 2018 |
| In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet? N Echeverría, V Comas, F Aldunate, P Perbolianachis, P Moreno, ... World Journal of Hepatology 13 (10), 1234-1268, 2021 | 11 | 2021 |
| An evolutionary insight into Newcastle disease viruses isolated in Antarctica M Sonora, P Moreno, N Echeverría, S Fischer, V Comas, A Fajardo, ... Archives of virology 160, 1893-1900, 2015 | 10 | 2015 |
| Genome-wide prediction of microRNAs in Zika virus genomes reveals possible interactions with human genes involved in the nervous system development J Cristina, N Echeverría, F Gambaro, A Fajardo, P Moreno bioRxiv, 070656, 2016 | 5 | 2016 |
| Evaluation of SYBR green real time PCR for detecting SARS-CoV-2 from clinical samples Á Fajardo, M Pereira-Gómez, N Echeverría, F López-Tort, ... bioRxiv, 2020.05. 13.093609, 2020 | 4 | 2020 |
| Resistance-associated substitutions and response to treatment in a chronic hepatitis C virus infected-patient: an unusual virological response case report F Aldunate, N Echeverría, D Chiodi, P López, A Sánchez-Cicerón, ... BMC Infectious Diseases 21 (1), 387, 2021 | 3 | 2021 |
| Molecular evolution of hepatitis C virus: from epidemiology to antiviral therapy (current research in Latin America) N Echeverría, P Moreno, J Cristina Human Virology in Latin America: From Biology to Control, 333-359, 2017 | 3 | 2017 |
| P1869: KPC-producing Klebsiella pneumoniae in Uruguay: first two clinical cases and isolates' characteristics report A Ingold, N Echeverria, A Acevedo, G Borthagaray, R Vignoli, J Viroga, ... Clinical Microbiology & Infection 18, 531, 2012 | 1 | 2012 |
| Mixed Infections Unravel Novel HCV Inter-Genotypic Recombinant Forms within the Conserved IRES Region N Echeverría, F Gámbaro, S Beaucourt, M Soñora, N Hernández, ... Viruses 16 (4), 560, 2024 | | 2024 |
| In the era of rapid mRNA-based vaccines: why is there no effective hepatitis C virus vaccine yet? N Echeverría Chagas, V Comas Almada, F Aldunate Caramori, ... World Journal of Hepatology, 2021, 13 (10): 1234-1268., 2021 | | 2021 |
| Resistance-associated substitutions and response to treatment in a chronic hepatitis C virus infected-patient: an unusual virological response case report F Aldunate Caramori, N Echeverría Chagas, D Chiodi, P López, ... BMC Infectious Diseases, 2021, 21: 387., 2021 | | 2021 |
Pilar MorenoLaboratorio de Virología Molecular, Facultad de Ciencias, Universidad de la República, Uruguay. Laboratorio de Evolución Experimental de Virus, Institut Pasteur de Montevideo, Uruguay.Adresse e-mail validée de fcien.edu.uy
